Tag Archives: Neurotech Leaders Forum

Neurotech Reports Announces Thomas Stieglitz, Ph.D., as Keynote Speaker for the Second Annual Neurotech Leaders Forum imec

SAN FRANCISCO, Calif., May 14, 2026 (SEND2PRESS NEWSWIRE) — Neurotech Reports today announced that Thomas Stieglitz, Ph.D., a globally recognized expert in neural engineering and implantable neurotechnology, will keynote the Second Annual Neurotech Leaders Forum imec, taking place June 23-24, 2026, in Leuven, Belgium.

Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec.

The Neurotech Leaders Forum brings together senior executives, investors, researchers, clinicians, and technology developers working at the forefront of neurotechnology, bioelectronic medicine, and brain-computer interface innovation. The event serves as a platform for examining emerging technologies, commercialization trends, investment activity, and the evolving direction of the neurotech industry across Europe and internationally.

“Dr. Thomas Stieglitz represents the kind of visionary leadership that continues to drive the neurotechnology field forward,” said James Cavuoto, editor and publisher of Neurotech Reports. “His perspective on the convergence of engineering, neuroscience, and clinical application will provide tremendous value for attendees from across the neurotech ecosystem.”

“Advances in neural interfaces and bioelectronic medicine are creating entirely new possibilities for treating neurological disorders and restoring function,” said Dr. Stieglitz. “I am honored to participate in this year’s Neurotech Leaders Forum imec and contribute to the conversation about the future of neurotechnology.”

Dr. Stieglitz is widely recognized for his contributions to neural interface technologies and implantable systems aimed at restoring and modulating nervous system function. Throughout his career, he has combined academic leadership with entrepreneurial innovation, co-founding companies focused on neural implants and neuromodulation therapies. He has authored more than 200 scientific journal articles, contributed extensively to conference literature, and is named on dozens of patents spanning neurotechnology and biomedical engineering.

Launched in 2025, the Neurotech Leaders Forum imec has quickly become a key meeting point for neurotechnology executives, researchers, and investors from across Europe and North America. The 2026 Forum will bring together leaders in neurostimulation, brain-computer technologies, implantable devices, AI-enabled neurotechnology, and investment at imec, one of Europe’s leading research and innovation centers.

Additional information and registration details are available at: https://www.neurotechreports.com/pages/leadersforum-europe.html

More information about imec is available at: https://www.imec-int.com/

ABOUT NEUROTECH REPORTS

Neurotech Reports, part of Cambridge Innovation Institute, is a leading source of market research, industry analysis, and business news covering neurotechnology, neuromodulation, and bioelectronic medicine. Through its publications and executive conferences, the company provides insights into emerging technologies, commercial trends, and investment activity shaping the global neurotech industry. Learn more: https://www.neurotechreports.com/

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/26-0514-s2p-stieglitz-300dpi.webp

Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec

LOGO: https://www.neurotechreports.com/images/nlf-imecFlag-horiz.png

NEWS SOURCE: Neurotech Reports

This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/neurotech-reports-announces-thomas-stieglitz-ph-d-as-keynote-speaker-for-the-second-annual-neurotech-leaders-forum-imec/

Two Prominent Professors to Keynote 25th Annual Neurotech Leaders Forum

SAN FRANCISCO, Calif., Aug. 11, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that two prominent figures in the field of neurotechnology will keynote the 2025 Neurotech Leaders Forum, which takes place November 5-6 in San Francisco. Edward Chang, chair of the department of neurological surgery at UC San Francisco, will discuss future applications of implanted brain sensing and stimulation devices.

Image caption: Prof. Edward Chang, M.D., from UC San Francisco (L) and J. Thomas Mortimer, Ph.D., Emeritus from Case Western University (R) will keynote the 2025 Neurotech Leaders Forum in San Francisco.

J. Thomas Mortimer, emeritus professor of biomedical engineering at Case Western Reserve University, will discuss his history as a pioneer developing implanted neurostimulation systems for chronic pain, diaphragm pacing, and bladder control.

The 25th annual event will also feature sessions devoted to the business of neuromodulation, the investment outlook for neurotechnology, the convergence of AI and BCI technologies, new realities in regulatory and reimbursement policies, and several other topics. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate panel discussions with key industry leaders.

Several panelists and presenters were recently added to the agenda for the two-day conference. New speakers include Ryan Field, CEO of Kernel; Andreas Forland, CEO of Cognixion; and Oliver Armitage, newly appointed vice president of Axoft. Venture capital professionals participating in the meeting include Mir Imran, managing partner at InCube Ventures, and Lu Zhang, founder and managing partner of Fusion Fund.

Among the new presenters this year are Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain and Tetiana Aleksandrova, CEO of Subsense, Inc., which is developing a nonsurgical nanoparticle-based BCI system.

The Platinum Sponsor at this year’s event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Silver sponsors include Velentium and Valtronic.

“As we celebrate our 25th year covering the neurotechnology industry, it’s gratifying to have Prof. Mortimer, one of the founders of the field, and Prof. Chang, one of the most promising researchers and entrepreneurs, talk about the past and future of our industry,” said James Cavuoto, editor and publisher of Neurotech Reports.

Neurotech Reports has extended the early-bird registration deadline until September 12, 2025.

Also, Neurotech Reports still has openings for a small number of startup and early-stage firms who would like to present during one of two Entrepreneur Panels at the conference.

To apply, visit this link: https://www.neurotechreports.com/pages/nlf-presenter-application.html

For more information, contact Neurotech Reports at 415 546 1259 or visit https://www.neurotechreports.com/.

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0811-s2p-ntpchangmortimer-300dpi.jpg

Neurotech Reports logo: https://www.neurotechreports.com//images/neurotech_business_SimpleBug.png

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/two-prominent-professors-to-keynote-25th-annual-neurotech-leaders-forum/

Neurotech Reports Announces First European Leaders Forum

SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference.

Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium.

Tim Denison, Ph.D. FREng, co-founder of Amber Therapeutics, will keynote the conference. Denison also holds a joint appointment in engineering science and clinical neurosciences at Oxford University, where he explores the fundamentals of physiologic closed-loop systems. Prior to that, he was a technical fellow at Medtronic plc and vice president of research & core technology for the Restorative Therapies Group, where he helped oversee the design of next generation neural interface and algorithm technologies for the treatment of chronic neurological disease.

At the conference, Neurotech Reports editor James Cavuoto will offer an update on the state of the European neuromodulation industry. Neurotech Reports editors JoJo Platt, Jeremy Koff, and Victor Pikov will moderate sessions devoted to peripheral nerve stimulation, bioelectronic medicine applications, venture capital investment, and regulatory and reimbursement issues affecting neurotech startups and emerging firms. Imec executives Peter Peumans, Paru Deshpande, and Barun Dutta (who conceived of, and led the Neuropixels program at imec since its inception) will also offer updates on technology advances at the European research and innovation center.

Executives from several emerging neurotechnology startups, including Italian firm WISE srl and German firm Precisis, will also present at the conference during multiple entrepreneur panels. In addition to imec, sponsors of the conference include Cirtec Medical, MST, Valtronic, and Osypka.

Neurotech Reports will also produce the 8th Annual Bioelectronic Medicine Forum on April 10, 2025 in New York City, and the 25th Annual Neurotech Leaders Forum San Francisco, on November 5-6, 2025.

For more information, contact Neurotech Reports at 415 546 1259 or visit: https://neurotechreports.com/pages/leadersforum-europe.html.

MULTIMEDIA:

Image link for media: https://www.Send2Press.com/300dpi/25-0130-s2p-ntrep-timdenison-300dpi.jpg

Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium.

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/neurotech-reports-announces-first-european-leaders-forum/

Promising Neurotechnology Startups to Present at the 24th Neurotech Leaders Forum

SAN FRANCISCO, Calif., Oct. 15, 2024 (SEND2PRESS NEWSWIRE) — Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forum in San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention.

Image caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum.

Also presenting for the first time will be Katya Sverdlov, CEO and co-founder of JelikaLite, a clinical stage medtech company focused on the treatment of autism. Another new presenter is Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain.

Other entrepreneur presenters at this year’s conference include Emily Mirro, President of SynchNeuro Inc., Andy Gotshalk, CEO, Neurologic Solutions, Luca Ravagnan, CEO of Italian firm WISE srl, Kial Gramley of BackStop Neural, and Imanuel Lerman, CEO, InflammaSense, Inc.

Raymond Cohen, CEO of Axonics Inc., will keynote the 24th annual event—the most established in the industry. Mr. Cohen has served as CEO and member of the board of directors of Axonics since co-founding the company in October 2013. Axonics recently announced it would be acquired by Boston Scientific in a $3.7 billion deal.

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled “BCI Frenzy: Separating the Facts from the Hype in the Brain Implant Market,” which will feature executives from several BCI firms. Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled “Market Share Battles: Neuromodulation’s Competitive Outlook.” Neurotech Reports editor James Cavuoto will moderate a session titled “Looking for the Exit: Investors Exploit Renewed Interest in Neurotech,” which will feature a discussion with key VC professionals. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled “Biomarking Your Territory: Neurosensing Technologies Enhance Closed-Loop Neuromodulation.”

Platinum Sponsor at this year’s event is Cirtec Medical. MST is Gold Sponsor. Valtronic, Velentium, and Neo-Bionica are Silver Sponsors, while TTP, Osypka, Corundum Neuroscience, Focus, and CorTec are Bronze Sponsors.

For more information, contact Neurotech Reports at 415 546 1259 or visit: http://neurotechreports.com/pages/leadersforum.html.

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/24-1015-s2p-ray-cohen-300dpi.jpg

Caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum in San Francisco, November 6-7, 2024.

NEWS SOURCE: Neurotech Reports

To view the original story, visit: https://www.send2press.com/wire/promising-neurotechnology-startups-to-present-at-the-24th-neurotech-leaders-forum/

Emerging Neurotechnology Startups to Present at 2023 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Among the new and emerging neurotech firms presenting at the conference are Opto Biosystems, a U.K. developer of novel diagnostics for brain cancer, NeuraLace Medical, a San Diego-based manufacturer of noninvasive therapies for treating chronic pain, Spark Biomedical, a Texas firm developing noninvasive therapies for treating addiction, and Harmonic Pain Solutions, an Atlanta, GA-area developer of wearable pain devices that use mechanical stimulation.

Jim Schuermann, president and CEO of Saluda Medical, will deliver the keynote address on the morning of November 6. He will speak on the topic "New Directions in Neuromodulation."

Daniel Kraft, founder of NextMed Health, chair of medicine for Singularity University, and chair of the XPrize Pandemic & Health Alliance, will deliver a keynote address on November 7 devoted to the topic, "The Future of Health and Medicine: Where Can Technology Take Us?" Kraft is board certified in internal medicine and pediatrics and completed fellowships in hematology/oncology and bone marrow transplantation at Stanford. He has given six TED & TEDMED talks.

Another featured presenter will be Prasad Shirvalkar, an associate professor at UC San Francisco School of Medicine, who recently co-authored a seminal paper relating to pain biomarkers. Chris Rozell, a professor at Georgia Tech, who recently coauthored a paper on biomarkers for depression, will also make a presentation at the event.

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled "Neurotech Investment: Bouncing Back from the Downturn," which will feature advice and recommendations from several venture capital professionals, including Sara Shnider from Joy Ventures, Martin Dieck from Neurotechnology Investors, and Suraj Mudichintala from Action Potential Venture Capital.

Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled "Changing Landscape: New SCS and PNS Vendors Enter the Scene," which will examine the current competitive environment in neuromodulation. Neurotech Reports editor James Cavuoto will moderate a session titled "Interpreting the Data: Neuromodulation Vendors Ward Off Negative Publications. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled "Choosing Our Role Models: What Neurotech Can Learn from Other Healthcare Industries."

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic, Velentium, Focus, Neo-Bionica, and Iris Biomedical are Silver Sponsors, while TTP and Microdul are Bronze sponsors.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: https://www.neurotechreports.com/

Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Mudit Jain, Ph.D., general partner at VC firm Treo Ventures, will keynote the conference. Dr. Jain has more than two decades of medical device industry experience across company formation, R&D, business development, and venture capital, with a global perspective on healthcare based on his experiences in the U.S., Ireland, and India. He is the co-founder of NuXcel, a medical device accelerator, and also serves as chairman of the board of ShiraTronics Inc., a NuXcel spinoff. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

"The neurotechnology industry has emerged as one of the most promising areas of healthcare technology, and Neurotech Reports has been following the space longer than any other organization," said James Cavuoto, editor and publisher at Neurotech Reports. "This year's conference-our 22nd annual-will offer unique insights for management and investment professionals involved with the industry."

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to reimbursement, securing funding, the new competitive landscape in neuromodulation, deep-brain stimulation, and neurorehabilitation. New this year is a session devoted to privacy, security, and ethics in neurotechnology.

Among the companies presenting this year are gBrain, a Korean manufacturer of graphene-based brain engineering systems, Motif Neurotech, a Texas developer of compact implanted brain stimulation devices for treating depression, and REVAI, a Canadian manufacturer of AI-powered vagus nerve stimulation systems for learning and wellness applications. Other presenting companies are Neural Dynamics Technologies, NeuroSigma, Roga Life, NXTStim, PathMaker Neurosystems, NeuronOff, WISE Srl, Sana Health, and Zeto Inc.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Valtronic and MCRA are Silver Sponsors, and the Cleveland FES Center is Bronze Sponsor.

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/leadersforum.html.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 12 promising neurotechnology startups and early-stage firms will present at the 2022 Neurotech Leaders Forum in San Francisco, November 7-8. The 22nd annual event - the most established in the industry - will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: https://www.neurotechreports.com/

Neurotech Reports Announces Launch of New Publication Serving Bioelectronic Medicine Industry

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the San Francisco, California publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report, is the first industry newsletter devoted to bioelectronic medicine, which refers to the therapeutic use of electrical or other forms of stimulation, rather than drugs, to treat disorders.

The publication was introduced at the Neurotech Leaders Forum, which takes place November 8-9, 2021 in San Francisco.

James Cavuoto, editor and publisher at Neurotech Reports, said that bioelectronic medicine promises to alter fundamentally the nature of therapeutic interventions for treating a wide variety of conditions, ranging from inflammatory disorders to bowel and bladder disorders, and a host of other potential markets in which drug therapies have fallen short. "We plan to be the most up-to-date and authoritative source of information and analysis of the market, the major players, deal activity, and important clinical research in bioelectronic medicine," he said.

Cavuoto is the lead author of Neurotech Report's market research study, "The Market for Bioelectronic Medicine: 2022-2027." Neurotech Reports launched the Bioelectronic Medicine Forum in New York City in 2018, and plans to return to New York for the fifth annual event in April 2022.

Helping launch the new publication is consulting editor Susan Schaeffer, former editor of BioCentury, the leading industry newsletter for the pharmaceutical industry. In that role, she advanced new thinking in clinical trial development, regulation, pricing, and market access-factors that will be critical in bioelectronic medicine. She is also a member of the National Academies Forum on Drug Discovery, Development, and Translation and founder of a patient education nonprofit.

"Bioelectronic medicine is rapidly bringing a new modality forward for targeted and personalized medicine-a space that has been dominated by biopharmaceutical companies," said Schaeffer. "BioElectRx Business Report will have a particular focus on the potential for collaboration between these historically separate sectors, and will shed light on the potential of this new technology to treat serious diseases, either without, or in conjunction with drugs."

Contributing editor Jo Jo Platt, who has worked with many bioelectronic medicine pioneers during her career, will round out the editorial team for BioElectRx Business Report.

For more information on subscribing to BioElectRx Business Report, contact Neurotech Reports at 1-415-546-1259, or visit: https://www.neurotechreports.com/pages/BioElectRx-newsletter.html

For more information on Neurotech Reports, visit: https://neurotechreports.com/

Learn more about the Neurotech Leaders Forum at: https://neurotechreports.com/pages/leadersforum.html

Neurotech Reports, the San Francisco, California publisher of market intelligence for the healthcare industry, announced the launch of a new monthly newsletter covering the bioelectronic medicine industry, one of the newest and fastest growing industry segments. The publication, BioElectRx Business Report, is the first industry newsletter devoted to bioelectronic medicine.

Related link: http://www.neurotechreports.com/

Fifteen Neurotechnology Startups to Present at the 2019 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Josh Makower, general partner at VC firm New Enterprise Associates, will keynote on the first day of the conference. Makower is cofounder of the Stanford Byers Biodesign Center and also founder and executive chairman of ExploraMed, a medical device incubator that has created eight companies over the past 20 years.

Robert Knight, professor of psychology and neuroscience and director emeritus of the Helen Wills Neuroscience Institute at UC Berkeley, will deliver the keynote on the second day of the event. Knight is the recipient of the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health for distinguished contributions to neurological research. He is also the chief science advisor of Neurofocus Inc., the consumer neurotech spinoff company acquired by market research firm Nielsen.

The agenda for this year's event includes panel discussions on a number of topics, including sessions devoted to clinical trials, securing funding, the new competitive landscape in neuromodulation, closed-loop stimulation, and neurorehabilitation. New this year is an editorial roundtable featuring Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta, who will each offer their perspectives on issues confronting the industry.

Among the companies presenting this year are Saluda Medical, Nia Therapeutics, Neuroelectrics, Humm, Evoke Neuroscience, Neural Dynamics Technologies, Spark Biomedical, Thermaquil, Humm, Neuraura, CareWear, Rune Labs, Neural Signals, and BIOS.

The Platinum Sponsor at this year's event is Cirtec Medical. Micro Systems Technology is the Gold Sponsor. Maynard Cooper and Integer are Silver Sponsors, and RBrooks Group, Senso Medical, and the Cleveland FES Center are Bronze Sponsors.

"We're excited about the lineup of speakers at this year's event," said James Cavuoto, editor and publisher at Neurotech Reports. "As in the past, attendees will have many opportunities to interact with potential partners and colleagues."

For more information on attending or sponsoring, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/leadersforum.html.

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Related link: http://www.neurotechreports.com/

Neuroprosthetics Pioneer to Keynote at the 2018 Neurotech Leaders Forum in San Francisco

SAN FRANCISCO, Calif. /ScoopCloud/ -- Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Peckham is a Distinguished University Professor and Donnell Institute Professor of Biomedical Engineering at Case Western Reserve University. He is also associate director of technology transfer at the Cleveland FES Center and the founder of the Institute for Functional Restoration. The event will take place October 15-16 in San Francisco, Calif.

Frank Fischer, CEO of NeuroPace Inc., has also been added to the agenda as a keynote speaker. Other additions include Eddie Chang, co-director of the Center for Neural Engineering at UC Berkeley and UC San Francisco, Philip Starr, professor of neurosurgery at UCSF, Michael Ackermann, CEO of Presidio Medical, Bashar Badran from the U.S. Army Research Laboratories, Cristin Welle, a former FDA employee and now assistant professor at University of Colorado, Nick Langhals, Neural Engineering Program Manager at the National Institutes of Health, and John Donoghue, director of the Wyss Center for Neuro and Bioengineering.

Executives from several early-stage and emerging neurotech startups will also make presentations during the event. These include Manfred Franke, founder and CEO of Neuronoff Inc., Bill Edelman, chairman of Highland Instruments, Erik Nilsen, CEO of Bio-Signal Technologies, LLC, and Howard Leonhardt, CEO of CerebraCell.

The conference returns to the Embassy Suites San Francisco Airport-Waterfront in Burlingame, Calif. Platinum Sponsor at this year's conference will be Cirtec Medical. Micro Systems Technologies is the Gold Sponsor. Other sponsors include IMEC, Cactus Semiconductor, Hereaus, Senso Medical, RBrooks Group, Maynard Cooper, Cleveland FES Center, along with partners the International Neuromodulation Society and Neuromodec.

"We're pleased to have such a distinguished lineup of speakers at the 2018 Neurotech Leaders Forum," said James Cavuoto, editor and publisher of Neurotech Reports. Neurotech Reports, founded in 2001, is the leading and longest-established publishing and market-research firm covering the neurotechnology industry.

For more information, contact James Cavuoto at 415-546-1259 or visit http://www.neurotechreports.com/pages/leadersforum.html.

Neurotech Reports today announced that the keynote speaker at the 18th annual Neurotech Leaders Forum will be Hunter Peckham, a pioneer in the field of neuroprosthetics, technology that restores movement for people living with paralysis.

Related link: http://www.neurotechreports.com/